Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 3Recruiting 2Not yet recruiting 2Completed 2Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Stomach Neoplasms 15Rectal Neoplasms 13Triple Negative Breast Neoplasms 10Pancreatic Neoplasms 7Neoplasm Metastasis 7Nasopharyngeal Carcinoma 6Colonic Neoplasms 6Neoplasms 4Gallbladder Neoplasms 4Cholangiocarcinoma 4Anus Neoplasms 4Adenocarcinoma Of Esophagus 4Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Somatostatinoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Klatskin Tumor 2Esophageal Squamous Cell Carcinoma 2Colorectal Cancer Metastatic 2Clinical Stage I Gastric Cancer AJCC v8 2Biliary Tract Neoplasms 2Adenoma, Islet Cell 2Squamous Cell Carcinoma of Head and Neck 1Spinocerebellar Degenerations 1Solid Cancer 1Skin Neoplasms 1Rectal Diseases 1

Interventions

Dexamethasone 18Cyclophosphamide 16fludarabine 11pomalidomide 9pembrolizumab 9carfilzomib 9daratumumab 7Rituximab 7Lenalidomide 7Calcium Dobesilate 7fludarabine phosphate 6Gemcitabine 6Cisplatin 6Bortezomib 6venetoclax 5elotuzumab 4isatuximab 3blinatumomab 3Vincristine 3Radiotherapy 3Prednisone 3Etoposide 3Doxorubicin 3Cytarabine 3tisagenlecleucel 2selinexor 2ruxolitinib 2ixazomib 2dexamethasone 21-phosphate 2cabazitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Recurrence × Capecitabine × Clear all
NCT05126719 2026-02-06

A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma

Shanghai Miracogen Inc.

Phase 2 Active not recruiting
238 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT05990543 2025-09-08

Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer

Korea University Anam Hospital

Phase 1/2 Active not recruiting
59 enrolled
Gastrointestinal

Recurrence, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡